BioAgilytix appoints top healthcare executive David King to its Board of Directors

The Latest News from BioAgilytix

24 August, 2020

BioAgilytix’s Durham, North Carolina Laboratory Receives Certificate of Accreditation from COLA

BioAgilytix has received its Certificate of Accreditation for high complexity testing in the diagnostic immunology specialty from the Commission on Office Laboratory Accreditation (COLA) for its U.S. facility in Durham, North Carolina.

Read More

19 August, 2020

BioAgilytix Welcomes Marianne Scheel Fjording, Ph.D. to Team as Scientific Officer

Dr. Fjording will be based at BioAgilytix’s European laboratory in Hamburg, Germany and will provide scientific and regulatory oversight to BioAgilytix’s team in the development and implementation of strategies for bioanalytical assay development and regulated assay validation.

Read More

3 August, 2020

BioAgilytix Rebrands Its Cambridge Biomedical Diagnostic Testing Division to BioAgilytix Diagnostics

The new name is reflective of BioAgilytix’s plan, which was set forth following its acquisition of Boston-based Cambridge Biomedical in late 2019, to fully integrate Cambridge Biomedical’s clinical and diagnostic testing capabilities into BioAgilytix’s global service offerings.

Read More

1 July, 2020

Analytical Assays Determine Biosimilar Product Quality

BioAgilytix supplies its assay expertise to describe the appropriate analytical assays needed to determine and ensure that biosimilar critical quality parameters are on track.

Read More

30 June, 2020

Chad Briscoe, Ph.D. Joins BioAgilytix Leadership Team as Chief Scientific Officer

In this role, Dr. Briscoe will provide scientific and regulatory oversight to BioAgilytix’s global teams with strategic guidance in line with emerging scientific developments.

Read More

25 June, 2020

BioAgilytix Welcomes Mike Nicholson, Ph.D. to Leadership Team as Vice President, Operations

In this role, Dr. Nicholson will oversee bioanalytical operations and scientific team development across BioAgilytix’s laboratories in both the USA and Europe, with particular focus leading the organization’s Gene and Cell Therapy bioanalytical services.

Read More

6 May, 2020

Frank Horling, Ph.D. Joins BioAgilytix Leadership Team as General Manager, Europe

In this role, Dr. Horling will lead Operations, Finance, HR, and Facilities for BioAgilytix’s European business and its laboratory located in Hamburg, Germany.

Read More

29 April, 2020

BioAgilytix Welcomes Jim McNally, Ph.D. to Leadership Team as Chief Scientific Officer

Dr. McNally brings with him an extensive background in bioanalytical assay development and program leadership working for almost 20 years in the pharmaceutical and biotechnology industry.

Read More

12 December, 2019

BioAgilytix Welcomes Dominic Marasco to Leadership Team as Chief Commercial Officer

Mr. Marasco will provide strategic direction to BioAgilytix’s global business development and marketing functions / teams to further expand worldwide adoption of the company’s premier bioanalytical services.

Read More